POSAA wants the drugs on the PBS for the condition once called PCOS, where they're used off-label. Wegovy's revised listing bid goes back to the committee next month.
Recap by typeshit. Full story at The Guardian.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
The bank expects stronger tablet sales. It also points to lower margins and slower earnings growth for Novo Nordisk over the long run.
One paper found over 20% of patients had a deficiency after a year. A U of T pharmacist says many people now get a prescription with no follow-up support.
Loading…